These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 11714894

  • 1. Interaction of the sulfonylthiourea HMR 1833 with sulfonylurea receptors and recombinant ATP-sensitive K(+) channels: comparison with glibenclamide.
    Russ U, Lange U, Löffler-Walz C, Hambrock A, Quast U.
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1049-55. PubMed ID: 11714894
    [Abstract] [Full Text] [Related]

  • 2. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.
    Felsch H, Lange U, Hambrock A, Löffler-Walz C, Russ U, Carroll WA, Gopalakrishnan M, Quast U.
    Br J Pharmacol; 2004 Apr; 141(7):1098-105. PubMed ID: 15023854
    [Abstract] [Full Text] [Related]

  • 3. Glibenclamide binding to sulphonylurea receptor subtypes: dependence on adenine nucleotides.
    Hambrock A, Löffler-Walz C, Quast U.
    Br J Pharmacol; 2002 Aug; 136(7):995-1004. PubMed ID: 12145099
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels.
    Liu Y, Ren G, O'Rourke B, Marbán E, Seharaseyon J.
    Mol Pharmacol; 2001 Feb; 59(2):225-30. PubMed ID: 11160857
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Coexpression with the inward rectifier K(+) channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamide.
    Russ U, Hambrock A, Artunc F, Löffler-Walz C, Horio Y, Kurachi Y, Quast U.
    Mol Pharmacol; 1999 Nov; 56(5):955-61. PubMed ID: 10531400
    [Abstract] [Full Text] [Related]

  • 7. Characterization of a mutant sulfonylurea receptor SUR2B with high affinity for sulfonylureas and openers: differences in the coupling to Kir6.x subtypes.
    Hambrock A, Löffler-Walz C, Russ U, Lange U, Quast U.
    Mol Pharmacol; 2001 Jul; 60(1):190-9. PubMed ID: 11408614
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lipids modulate ligand binding to sulphonylurea receptors.
    Klein A, Lichtenberg J, Stephan D, Quast U.
    Br J Pharmacol; 2005 Aug; 145(7):907-15. PubMed ID: 15895108
    [Abstract] [Full Text] [Related]

  • 10. The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide.
    Sunaga Y, Gonoi T, Shibasaki T, Ichikawa K, Kusama H, Yano H, Seino S.
    Eur J Pharmacol; 2001 Nov 09; 431(1):119-25. PubMed ID: 11716850
    [Abstract] [Full Text] [Related]

  • 11. The mutation Y1206S increases the affinity of the sulphonylurea receptor SUR2A for glibenclamide and enhances the effects of coexpression with Kir6.2.
    Stephan D, Stauss E, Lange U, Felsch H, Löffler-Walz C, Hambrock A, Russ U, Quast U.
    Br J Pharmacol; 2005 Apr 09; 144(8):1078-88. PubMed ID: 15711591
    [Abstract] [Full Text] [Related]

  • 12. Molecular basis and characteristics of KATP channel in human corporal smooth muscle cells.
    Insuk SO, Chae MR, Choi JW, Yang DK, Sim JH, Lee SW.
    Int J Impot Res; 2003 Aug 09; 15(4):258-66. PubMed ID: 12934053
    [Abstract] [Full Text] [Related]

  • 13. ATP-Sensitive K+ channel modulator binding to sulfonylurea receptors SUR2A and SUR2B: opposite effects of MgADP.
    Hambrock A, Löffler-Walz C, Kloor D, Delabar U, Horio Y, Kurachi Y, Quast U.
    Mol Pharmacol; 1999 May 09; 55(5):832-40. PubMed ID: 10220561
    [Abstract] [Full Text] [Related]

  • 14. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
    Gribble FM, Tucker SJ, Seino S, Ashcroft FM.
    Diabetes; 1998 Sep 09; 47(9):1412-8. PubMed ID: 9726229
    [Abstract] [Full Text] [Related]

  • 15. Effects of a novel cardioselective ATP-sensitive potassium channel antagonist, 1-[[5-[2-(5-chloro-o-anisamido)ethyl]-beta-methoxyethoxyphenyl]sulfonyl]-3-methylthiourea, sodium salt (HMR 1402), on susceptibility to ventricular fibrillation induced by myocardial ischemia: in vitro and in vivo studies.
    Billman GE, Houle MS, Englert HC, Gögelein H.
    J Pharmacol Exp Ther; 2004 Apr 09; 309(1):182-92. PubMed ID: 14722326
    [Abstract] [Full Text] [Related]

  • 16. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure.
    Dörschner H, Brekardin E, Uhde I, Schwanstecher C, Schwanstecher M.
    Mol Pharmacol; 1999 Jun 09; 55(6):1060-6. PubMed ID: 10347249
    [Abstract] [Full Text] [Related]

  • 17. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
    Schwanstecher M, Sieverding C, Dörschner H, Gross I, Aguilar-Bryan L, Schwanstecher C, Bryan J.
    EMBO J; 1998 Oct 01; 17(19):5529-35. PubMed ID: 9755153
    [Abstract] [Full Text] [Related]

  • 18. Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type K(ATP) channels.
    Chachin M, Yamada M, Fujita A, Matsuoka T, Matsushita K, Kurachi Y.
    J Pharmacol Exp Ther; 2003 Mar 01; 304(3):1025-32. PubMed ID: 12604678
    [Abstract] [Full Text] [Related]

  • 19. Cooperative binding of ATP and MgADP in the sulfonylurea receptor is modulated by glibenclamide.
    Ueda K, Komine J, Matsuo M, Seino S, Amachi T.
    Proc Natl Acad Sci U S A; 1999 Feb 16; 96(4):1268-72. PubMed ID: 9990013
    [Abstract] [Full Text] [Related]

  • 20. Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain.
    Chen M, Dong Y, Simard JM.
    J Neurosci; 2003 Sep 17; 23(24):8568-77. PubMed ID: 13679426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.